LH - Laboratory Corp. Of America Holdings
(NaN%)
SNP 500
Sell
Weak Growth
37%
based on last 5 year data.
Income Statement is MODERATE
Revenue Growth is 2.51%
Operating Income Growth is -49.49%
Net Income Growth is -67.32%
Earnings Per Share (EPS) Growth is -56.4%
Net Margin is 3.44%
Balance Sheet is WEAK
Current Asset to Current Liability Ratio is 1.17
Debt Ratio is 0.53
Current Debt to Net Income Ratio is 2.39
Total Debt to Total Assets Ratio is 0.3
Cash Flow is MODERATE
Cash from Operations Growth is -32.12%
Capital Expenditure is High
Net Increase in Cash is Positive
Long Term Score Trend is NEGATIVE
Investment Risk is Low
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Laboratory Corp. Of America Holdings (LH) - www.labcorp.com
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through its unparalleled diagnostics and drug development capabilities, company provides insights and accelerates innovations to improve health and improve lives. With more than 70,000 employees, Labcorp serves clients in more than 100 countries. Labcorp reported revenue of $14 billion in FY2020.Exchange - NEW YORK STOCK EXCHANGE INC.
Industry - Diagnostic Imaging Centers
Sector - Health Care and Social Assistance
CEO - Adam Schechter
Employees - 80,000
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2024 and future.
Know the Stock © 2024 and future.